UPDATE: Morgan Stanley Starts Sophia Genetics SA (SOPH) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech stocks weigh on Wall Street as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- U.S. EV market shows signs of bottoming out: Bernstein
Cowen Starts Sophia Genetics SA (SOPH) at Outperform
August 17, 2021 5:49 AM EDTCowen analyst Doug Schenkel initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Outperform rating.
The analyst comments "SOPH is an emerging leader in the decentralization of comprehensive genetic testing; the company also seeks to expand into adjacencies, such as... More
UPDATE: Credit Suisse Starts Sophia Genetics SA (SOPH) at Outperform
August 17, 2021 4:27 AM EDT(Updated - August 17, 2021 4:43 AM EDT)
Credit Suisse analyst Katie Tryhane initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Outperform rating and a price target of $22.00.
The analyst comments "SOPH is a healthcare technology company offering a decentralized software platform that leverages... More
JPMorgan Starts Sophia Genetics SA (SOPH) at Overweight
August 17, 2021 4:20 AM EDTJPMorgan analyst Tycho W. Peterson initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Overweight rating and a price target of $23.00.
For an analyst ratings summary and ratings history on Sophia Genetics SA... More
